Three-Year Outcomes of Neovascular Age-Related Macular Degeneration in Eyes That Do Not Develop Macular Atrophy or Subretinal Fibrosis

PURPOSE: To report the 36-month treatment outcomes of eyes with neovascular age-related macular degeneration (nAMD) receiving vascular endothelial growth factor (VEGF) inhibitors in daily practice who did not develop either subretinal fibrosis (SRFi) or macular atrophy (MA). METHODS: This is a retro...

Descripción completa

Detalles Bibliográficos
Autores principales: Gabrielle, Pierre-Henry, Nguyen, Vuong, Arnold, Jennifer J., Bhandari, Sanjeeb, Viola, Francesco, Tigchelaar-Besling, Odette A. M., Garay-Aramburu, Gonzaga, O'Toole, Louise, Cheung, Chui Ming Gemmy, Barthelmes, Daniel, Creuzot-Garcher, Catherine, Gillies, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572511/
https://www.ncbi.nlm.nih.gov/pubmed/34730771
http://dx.doi.org/10.1167/tvst.10.13.5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572511/
https://www.ncbi.nlm.nih.gov/pubmed/34730771
http://dx.doi.org/10.1167/tvst.10.13.5

Ejemplares similares